Lightnews — Scholar-powered news

LightNews

Latent Labs

@latentlabs.bsky.social

130 followers 6 following 29 posts

Frontier models for all molecules of life.

Posts Media Videos Starter Packs

Latent Labs @latentlabs.bsky.social · Aug 21

Read the full story behind our collaboration with AWS: tinyurl.com/Latent-xAWS

Mastering the machine: Latent Labs engineers the future of biology - AWS Startups

Latent Labs is breaking conventions of the past, offering a generative-AI powered approach to protein design that sidesteps and augments lab experiments.

Latent Labs @latentlabs.bsky.social · Aug 21

The AWS partnership has been providing scalable compute through Amazon SageMaker HyperPod and an incredible community that's accelerated our mission.

Latent Labs @latentlabs.bsky.social · Aug 21

Instead of waiting weeks or months for lab experiments, researchers can now get to precision breakthrough molecules at the push of a button.

Latent Labs @latentlabs.bsky.social · Aug 21

Our Latent-X model uses AI to design proteins and model molecular interactions – moving beyond what nature gives us to precisely engineering what we need for therapeutics, food tech, and climate solutions.

Latent Labs @latentlabs.bsky.social · Aug 21

🧬 From observational science to engineering – this is the transformation we're driving in biology.

Latent Labs @latentlabs.bsky.social · Aug 11

Latent-X is available with a free tier on our platform now: platform.latentlabs.com

Latent Labs - Beta

platform.latentlabs.com

Latent Labs @latentlabs.bsky.social · Aug 11

Latent-X has been available for over two weeks and we couldn't be more excited about the science already being done with it.

Our CEO @saakohl.bsky.social joined @bloomberg.com News Daybreak Europe today to talk why we're building it, and the impact it is having.

Watch here: tinyurl.com/yjzyhr23

Nvidia, AMD to Pay US 15% of China AI Chip Sales; Trump-Putin Summit | Daybreak Europe 8/11/2025

YouTube video by Bloomberg Television

www.youtube.com

Latent Labs @latentlabs.bsky.social · Jul 25

🔬 Mini-binders represent a new therapeutic modality — for targeted delivery, diagnostics, and therapeutic inhibitors.

For partnerships: [email protected]

Latent Labs @latentlabs.bsky.social · Jul 25

🚀 Available now on the Latent Labs Platform with free tier access:

* No-code interface
* Upload targets, select epitopes, generate binders
* 10x faster than previous methods
* Computational ranking for lab prioritization

Latent Labs @latentlabs.bsky.social · Jul 25

🧪 Lab-validated target specificity across all tested mini-binders.

See the all-against-all binding screen via our in-house mDisplay assay below:

Latent Labs @latentlabs.bsky.social · Jul 25

⚡ Watch Latent-X generate a picomolar mini-binders from scratch — solving the geometric puzzle of binding at the all-atom level in real-time.

Every atom placed with precision to create the biochemistry required for tight, specific binding.

Latent Labs @latentlabs.bsky.social · Jul 25

🔬 Look at the generated non-covalent bonds — hydrogen bonds, pi-stacking, van der Waals interactions.

Latent-X doesn't just predict binding; it generates the exact biochemical interactions needed for high affinity and specificity.

Latent Labs @latentlabs.bsky.social · Jul 25

🎯 Extensive lab validation shows leading performance:

* 100% target success rate (5/5 therapeutically relevant proteins)
* Picomolar binding affinities achieved
* 10-64% experimental hit rates
* Testing just ~100 designs per target vs millions traditionally

Latent Labs @latentlabs.bsky.social · Jul 25

🧬Latent-X is our first frontier model for protein design.

For mini-binders, our AI model achieved picomolar binding affinities — the strongest reported vs prior methods in head-to-head lab validation.

Explore our best binders here: platform.latentlabs.com

More details on the breakthrough in this🧵

Latent Labs @latentlabs.bsky.social · Jul 24

In extensive wet lab experiments, Latent-X achieved what would typically require millions of candidates by testing as little as 30-100 candidates per target—yet achieved strong binding affinities down to the picomolar ranges.

Sign-up for early access at: platform.latentlabs.com

Latent Labs - Beta

platform.latentlabs.com

Latent Labs @latentlabs.bsky.social · Jul 24

‘Latent Labs launches web-based AI model to democratize protein design.’

Thank you @techcrunch.com and Marina Temkin for the coverage.

Read the full story: tinyurl.com/Latent-X-Tec...

Latent Labs launches web-based AI model to democratize protein design | TechCrunch

The company claims that its model achieved state of the art on specific metrics.

Latent Labs @latentlabs.bsky.social · Jul 22

Starting with macrocycles and mini-binders, expanding to nanobodies and more. Our mission: make biology programmable to make drug design instantaneous.
Join early access: platform.latentlabs.com
Technical report: tinyurl.com/latent-X
Technical details: www.latentlabs.com/latent-x

Latent Labs @latentlabs.bsky.social · Jul 22

Latent-X solves the geometric puzzle of binding at the all-atom level, generating novel binders from scratch while obeying nature's biochemical rules.
Scientists can now access lab-validated AI workflows without needing AI expertise or infrastructure.

Latent Labs @latentlabs.bsky.social · Jul 22

Traditional drug discovery screens millions of random molecules with <1% hit rates. Latent-X flips this: we generate 30-100 precise designs per target and achieve lab success rates up to 100%.

The efficiency gains are dramatic.

Latent Labs @latentlabs.bsky.social · Jul 22

5 months from funding to shipping our first frontier model. Latent-X achieves state-of-the-art hit rates for macrocycles and mini-binders, with picomolar binding affinities — a breakthrough in de novo protein binder design.

Available now on our no-code platform!

Latent Labs @latentlabs.bsky.social · May 13

Learn more about the panel and the event here: uspharma.live.ft.com/agenda/sessi...

US Pharma and Biotech Summit 2025 Agenda - A FTLive Event

Discover the Agenda for the FT US Pharma and Biotech Summit 2025. Hear from CEOs, policymakers and senior business leaders as they discover the latest trends and innovations in life sciences.

uspharma.live.ft.com

Latent Labs @latentlabs.bsky.social · May 13

Catch @saakohl.bsky.social's panel with Glen Gowers, Michael Curtis, Amber Salzman, and Oliver Barnes at the @financialtimes.com Biotech Summit this Thursday discussing what the future holds for AI-driven drug discovery.

Latent Labs @latentlabs.bsky.social · May 6

Read more about how we’re working with AWS to put AI directly into the hands of biologists, pharma, and biotech innovators around the world: shorturl.at/0t63L

Latent Labs and AWS announce collaboration to scale generative AI for the Life Sciences - Latent Labs

www.latentlabs.com

Latent Labs @latentlabs.bsky.social · May 6

Latent Labs is partnering with @awscloud.bsky.social to super‑charge generative AI for the life sciences. Together, we’ll scale access to protein design tools that help scientists discover breakthrough therapies faster.

Latent Labs @latentlabs.bsky.social · Feb 13

"Latent Labs is building AI foundation models to 'make biology programmable', partnering with biotech and pharma to generate and optimize proteins."
Huge thanks to @techcrunch.com, our investors & supporters. Follow us as we push the frontiers of AI & biology.
techcrunch.com/2025/02/12/f...

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable | TechCrunch

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.